This inventor holds 1 USPTO granted patent. Top assignee: Karolinska Innovations Ab. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: Innovations by Chen Qijun in Malaria Research
Introduction
Chen Qijun is an innovative inventor based in Stockholm, Sweden. He has made significant contributions to the field of malaria research through his patented inventions. His work focuses on developing novel solutions to combat malaria, a disease that continues to affect millions worldwide.
Latest Patents
Chen Qijun holds a patent for "Malaria polypeptides." This invention relates to carbohydrates that can act as receptors for malaria antigens found on the surfaces of malaria-infected erythrocytes. The receptors described in his patent comprise negatively charged glycosaminoglycan-like moieties, preferably sulphated. Additionally, the invention includes novel malaria polypeptides that can act as ligands in relation to these receptors. The patent also encompasses the use of these polypeptides as medicaments, pharmaceutical compositions containing them, and antibodies directed against the new ligands.
Career Highlights
Chen Qijun is associated with Karolinska Innovations AB, where he continues to advance his research and development efforts. His work is crucial in the ongoing fight against malaria, contributing to the development of potential treatments and preventive measures.
Collaborations
Some of his notable coworkers include Antonio Barragan and Victor Fernandez. Their collaboration enhances the research efforts and innovation in the field of malaria treatment.
Conclusion
Chen Qijun's contributions to malaria research through his innovative patents highlight the importance of scientific advancements in combating infectious diseases. His work exemplifies the potential of targeted research in developing effective medical solutions.